7^th Global Cardiovascular Research and Clinical Cardiology October 30-31, 2024 Chicago, USA

This track can explore the role of genetic factors in cardiovascular diseases, including hereditary cardiomyopathies, familial hypercholesterolemia, and genetic predispositions to arrhythmias and coronary artery disease. It can also address the application of precision medicine approaches in risk prediction, diagnosis, and treatment selection

This track can cover novel pharmacological agents for the prevention and treatment of cardiovascular diseases, including mechanisms of action, efficacy, safety profiles, and clinical trial outcomes.

 It focuses on clinical trials investigating new treatments, diagnostic tools, and preventive measures for cardiovascular diseases. It can also cover epidemiological studies exploring the prevalence, risk factors, and outcomes of cardiovascular conditions.

• Pharmacological Trials
• Device Trials
• Preventive Trials
• Diagnostic Trials

This track can cover programs and interventions aimed at optimizing recovery and improving outcomes for patients with cardiovascular disease, including cardiac rehabilitation, risk factor management, and psychosocial support. It includes exercise testing, individualized exercise prescriptions, aerobic training, resistance training, flexibility exercises, and balance training. Topics may also cover exercise safety considerations, monitoring techniques, and exercise adherence strategies.

• Nutritional Counseling and Dietary Interventions
• Psychosocial Support and Behavioral Counseling

This track can focus on the diagnosis and management of congenital heart defects and acquired heart diseases in children and adolescents, including surgical and non-surgical interventions, long-term outcomes, and transition to adult care. This includes discussions on the embryology and pathophysiology of CHDs, genetic and environmental risk factors, and prenatal screening and diagnosis.

• Diagnostic Modalities in Pediatric Cardiology
• Acquired Heart Diseases in Pediatric Population
• Long-Term Follow-Up and Outcomes

This track can address strategies for cardiovascular disease prevention, including lifestyle modifications (e.g., diet, exercise, smoking cessation), risk assessment, and population health interventions. Guidance on the prescription of exercise and physical activity for cardiovascular health promotion and disease prevention. This includes recommendations for aerobic exercise, resistance training, flexibility exercises, and balance training. Topics may also include exercise intensity, frequency, duration, and progression, as well as considerations for special populations (e.g., older adults, individuals with chronic conditions).

• Nutrition and Dietary Interventions
• Smoking Cessation Programs

This track can cover the diagnosis and treatment of cardiac arrhythmias, including atrial fibrillation, ventricular tachycardia, and sudden cardiac death. Topics may include catheter ablation, antiarrhythmic drugs, implantable devices, and risk stratification. Diagnoswis and management of ventricular arrhythmias, including ventricular tachycardia (VT) and ventricular fibrillation (VF). This includes risk stratification, antiarrhythmic drug therapy, catheter ablation techniques, and implantable cardioverter-defibrillator (ICD) therapy. Discussions may also cover inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome) and sudden cardiac death risk assessment.

• Ventricular Arrhythmias
• Catheter Ablation Techniques
• Antiarrhythmic Drug Therapy
• Implantable Devices

It can focus on heart failure prevention, diagnosis, and management strategies, including pharmacotherapy, device therapy (e.g., pacemakers, implantable cardioverter-defibrillators), and advanced heart failure therapies (e.g., heart transplantation, ventricular assist devices).

Evaluation and management of patients with advanced heart failure refractory to conventional therapies. This includes heart transplantation, mechanical circulatory support (e.g., LVADs, temporary mechanical support devices), and palliative care. Topics may include patient selection criteria, perioperative management, long-term outcomes, and quality of life considerations.

• Heart Failure Prevention
• Heart Failure Diagnosis
• Pharmacological Therapy for Heart Failure
• Advanced Heart Failure Therapies

It can feature the latest techniques and technologies in interventional cardiology, including coronary angioplasty, stenting, structural heart interventions, and minimally invasive cardiac surgery. Topics may include advancements in balloon angioplasty, drug-eluting stents, bioresorbable scaffolds, and drug-coated balloons. Discussions may cover procedural approaches, lesion preparation strategies, stent optimization techniques, and long-term outcomes.

• Complex Coronary Interventions
• Structural Heart Interventions
• Peripheral Vascular Interventions
• Electrophysiology Procedures
• Minimally Invasive Cardiac Surgery
• Hybrid Procedures

It advances in imaging techniques such as echocardiography, cardiac MRI, CT angiography, and nuclear cardiology. It can also cover developments in diagnostic tools for early detection and risk stratification of heart disease.

• Echocardiography
• Cardiac MRI (Magnetic Resonance Imaging)
• CT (Computed Tomography) Angiography
• Nuclear Cardiology
• Multimodality Imaging